An article in the March 15, 2004, issue of BioWorld Today should have said that Momenta Pharmaceuticals Inc.'s product M-Enoxaparin is designed to be a technology-enabled generic version of Lovenox, a low-molecular-weight heparin from Aventis SA, of Strasbourg, France.

Editor's Note: The correction has been made in BioWorld Online.